In vivo modulation of the Parkinsonian phenotype by Nrf2
- 31 December 2006
- journal article
- research article
- Published by Elsevier BV in NeuroToxicology
- Vol. 27 (6), 1094-1100
- https://doi.org/10.1016/j.neuro.2006.07.019
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Sulforaphane reduces infarct volume following focal cerebral ischemia in rodentsNeuroscience Letters, 2006
- Novel cytoprotective mechanism of anti-parkinsonian drug deprenyl: PI3K and Nrf2-derived induction of antioxidative proteinsBiochemical and Biophysical Research Communications, 2006
- A Small-Molecule-Inducible Nrf2-Mediated Antioxidant Response Provides Effective Prophylaxis against Cerebral IschemiaIn VivoJournal of Neuroscience, 2005
- The genetic epidemiology of neurodegenerative diseaseJCI Insight, 2005
- Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTPCell and tissue research, 2004
- Manganese NeurotoxicityAnnals of the New York Academy of Sciences, 2004
- Antioxidants Enhance Mammalian Proteasome Expression through the Keap1-Nrf2 Signaling PathwayMolecular and Cellular Biology, 2003
- Molecular Pathways of Neurodegeneration in Parkinson's DiseaseScience, 2003
- Parkinson's DiseaseNeuron, 2003
- Dietary fat intake and the risk of incident dementia in the Rotterdam studyAnnals of Neurology, 1997